Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$20.8M |
| 2 |
Comcast
CMCSA
|
+$17.9M |
| 3 |
Mastercard
MA
|
+$17.9M |
| 4 |
McKesson
MCK
|
+$17.6M |
| 5 |
Reynolds Consumer Products
REYN
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$393M |
| 2 |
Entergy
ETR
|
+$96.9M |
| 3 |
CMS Energy
CMS
|
+$81.1M |
| 4 |
Consolidated Edison
ED
|
+$79.6M |
| 5 |
Ameren
AEE
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.65% |
| 2 | Financials | 7.8% |
| 3 | Healthcare | 7.73% |
| 4 | Consumer Discretionary | 6.21% |
| 5 | Consumer Staples | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Wells Fargo
WFC
$254B
| $553K | 0.03% |
19,257
-211,817
| -92% | -$9M |
|
452
Karyopharm Therapeutics
KPTI
$44.5M
| $552K | 0.03% |
+1,917
| New | +$529K |
|
453
Omega Healthcare
OHI
$14.1B
| $552K | 0.03% |
20,811
+4,837
| +30% | +$184K |
|
454
Zions Bancorporation
ZION
$9.95B
| $552K | 0.03% |
20,613
-40,678
| -66% | -$1.68M |
|
455
Masco
MAS
$14.5B
| $551K | 0.03% |
+15,953
| New | +$697K |
|
456
Nuveen Floating Rate Income Fund
JFR
$1.21B
| $549K | 0.03% |
+72,685
| New | +$674K |
|
457
StoneCo
STNE
$2.16B
| $547K | 0.03% |
+25,114
| New | +$958K |
|
|
PLYM
458
DELISTED
Plymouth Industrial REIT
PLYM
| $544K | 0.03% |
48,716
-3,913
| -7% | -$67.1K |
|
459
Tandem Diabetes Care
TNDM
$1.55B
| $544K | 0.03% |
8,451
-4,154
| -33% | -$291K |
|
460
Avista
AVA
$3.15B
| $537K | 0.03% |
+12,633
| New | +$608K |
|
|
JNPR
461
DELISTED
Juniper Networks
JNPR
| $533K | 0.03% |
27,836
-68,910
| -71% | -$1.55M |
|
462
Vertex Pharmaceuticals
VRTX
$139B
| $533K | 0.03% |
+2,238
| New | +$513K |
|
|
TLND
463
DELISTED
Talend S.A. American Depositary Shares
TLND
| $533K | 0.03% |
23,749
+3,062
| +15% | +$104K |
|
|
VGR
464
DELISTED
Vector Group Ltd.
VGR
| $532K | 0.03% |
+79,635
| New | +$702K |
|
465
Fastly Inc
FSLY
$3.97B
| $531K | 0.03% |
+27,959
| New | +$578K |
|
|
AVNS
466
DELISTED
Avanos Medical
AVNS
| $530K | 0.03% |
+19,699
| New | +$588K |
|
467
Inspire Medical Systems
INSP
$1.8B
| $530K | 0.03% |
+8,796
| New | +$651K |
|
|
ATH
468
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $530K | 0.03% |
21,349
-22,487
| -51% | -$895K |
|
469
Crane NXT
CXT
$2.89B
| $526K | 0.03% |
+30,814
| New | +$792K |
|
470
American Financial Group
AFG
$11.9B
| $525K | 0.03% |
+7,491
| New | +$723K |
|
471
Ciena
CIEN
$56B
| $525K | 0.03% |
13,178
+2,919
| +28% | +$120K |
|
472
Merck
MRK
$376B
| $521K | 0.03% |
+7,093
| New | +$557K |
|
473
Alcoa
AA
$13.7B
| $517K | 0.03% |
+83,994
| New | +$1.15M |
|
474
Cable One
CABO
$129M
| $515K | 0.03% |
+313
| New | +$500K |
|
475
Campbell Soup
CPB
$7.14B
| $515K | 0.03% |
+11,154
| New | +$536K |
|
Similar funds
Michael Gelband's Q1 2020 Portfolio in Review
As of Q1 2020, Michael Gelband held 1,928 positions worth $1.82B, down 66% from $5.33B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Michael Gelband withdrew a net $2.93B in Q1 2020, closing 898 positions and reducing 384 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $393M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Michael Gelband opened a new position in Mastercard worth $14.5M.
- Michael Gelband's largest Q1 2020 buy was Mastercard: 60,087 shares worth $14.5M.
- Michael Gelband added most to State Street Industrial Select Sector SPDR ETF in Q1 2020, an estimated $20.8M increase.
- Michael Gelband's biggest Q1 2020 reduction was Entergy, cutting an estimated $96.9M.
- Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q1 2020, selling an estimated $393M.
- Michael Gelband's ten largest holdings make up 32% of its $1.82B portfolio in Q1 2020.
- Michael Gelband opened 442 new positions and closed 898 in Q1 2020.
- Michael Gelband's portfolio value fell 66% quarter-over-quarter to $1.82B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2020, filed 15 May 2020.